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Abstract We cloned the genes of two members of the 
dermaseptin family, broad-spectrum antimicrobial peptides 
isolated from the skin of the arboreal frog Phyllomedusa bicolor. 
The dermaseptin gene Drg2 has a 2-exon coding structure 
interrupted by a small 137-bp intron, wherein exon 1 encoded a 
22-residue hydrophobic signal peptide and the first three amino 
acids of the acidic propiece; exon 2 contained the 18 additional 
acidic residues of the propiece plus a typical prohormone 
processing signal Lys-Arg and a 32-residue dermaseptin 
progenitor sequence. The dermaseptin genes Drg2 and Drglg2 
have conserved sequences at both untranslated ends and in the 
first and second coding exons. In contrast, Drglg2 comprises a 
third coding exon for a short version of the acidic propiece and a 
second dermaseptin progenitor sequence. Structural conservation 
between the two genes suggests that Drglg2 arose recently from 
an ancestral Drg2-like gene through amplification of part of the 
second coding exon and 3'-untranslated region. Analysis of the 
cDNAs coding precursors for several frog skin peptides of highly 
different structures and activities demonstrates that the signal 
peptides and part of the acidic propieces are encoded by 
conserved nucleotides encompassed by the first coding exon of 
the dermaseptin genes. The organization of the genes that belong 
to this family, with the signal peptide and the progenitor sequence 
on separate exons, permits strikingly different peptides to be 
directed into the secretory pathway. The recruitment of such a 
homologous 'secretory' exon by otherwise non-homologous genes 
may have been an early event in the evolution of amphibian. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
In recent years, the skin secretions of the arboreal frogs 
Phyllomedusa sauvagei and P. bicolor have become a pivotal 
model for the discovery of new mammalian-like hormones 
and neuropeptides [1], including dermorphin, dermenkephalin 
and deltorphins, D-amino acid-containing heptapeptides which 
exhibit exceptional affinity and selectivity for the \i- and 8-
opioid receptors, respectively [2]. The granular glands of the 
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skin also contain several a-helical cationic (lysine-rich) pep-
tides, 24—34 residues long, termed dermaseptins (Fig. 1). These 
peptides are broadly microbicidal, killing Gram-positive and 
Gram-negative bacteria as well as yeast, protozoan and fungi 
at the micromolar level [3,4]. Other frog species produce dis-
tinct repertoires of antimicrobial peptides whose members dif-
fer from dermaseptins with respect to their chain length, hy-
drophobicity, charge distribution and spectrum of activity 
(reviewed in [5]). All these peptides act completely unlike tra-
ditional antibiotic agents by permeating the microbial mem-
brane and impairing ability to carry out anabolic processes. 
Therefore, antimicrobial peptides from frog skin are of poten-
tial clinical interest since they are unlikely to induce the ac-
quisition of antibiotic resistance genes by bacterial pathogens. 
Although much is known about the function and structure 
of dermaseptins and related peptides [5], little is known about 
them at the gene level. We recently reported on the isolation 
and characterization of cDNAs encoding precursors of der-
maseptin Bl and dermaseptin B2 [6,7] and showed that pre-
prodermaseptins, preprodermorphin and preprodeltorphins 
all contain an almost identical amino-terminal domain includ-
ing a 22-residue signal peptide and a 20-23-residue acidic pro-
piece. The extensive similarities between the prepro regions of 
precursors encoding end products with very different struc-
tures and biological activities led to the suggestion that the 
genes encoding these peptides are all members of a same fam-
ily. We report here the cloning and sequencing of two genes 
for dermaseptins which represent the first sequence informa-
tion from P. bicolor genome and a comparison of the derma-
septin gene sequences with cDNAs coding precursors for sev-
eral frog skin peptides originating from various amphibian 
species. 
2. Materials and methods 
2.1. Genomic library construction 
High molecular weight genomic DNA was isolated from P. bicolor 
blood as described [8] and partially digested with Sau3A (Bethesda 
Research Laboratories). The fragments produced by this partial di-
gestion were separated on a 1CM10% sucrose velocity gradient. Frag-
ments containing the 10-20-kb fragments were pooled and dialyzed 
overnight against 4 1 of TE buffer to remove sucrose. After ethanol 
precipitation, the sized DNAs were partially filled in using dATP and 
dGTP to create ends that are compatible with those of 1 Fix II sup-
plied in the Lambda Fix ll/Xhol partial fill-in vector kit (Stratagene). 
The ligated DNAs were packaged in vitro using the protocol and 
reagents supplied with Gigapack II Gold packaging system (Strata-
gene). At this step, two different experiments were carried out: first, 
132000 clones arising from a single encapsidation reaction were 
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screened (see below); second, 1.4X 106 clones from five encapsidation 
reactions achieved with the same ligation reaction were plated on 
NZYCM plates to perform amplification of the library. The plates 
were overlaid with 10 ml of SM buffer and incubated overnight under 
gentle rocking at 4°C. After incubation, the bacteriophage suspension 
was recovered from each plate and pooled in a sterile container. After 
adding chloroform (5% final concentration), and incubating the mix-
ture for 15 min at room temperature, the cell debris were removed by 
centrifugation at 2000 Xg for 10 min. The recovered supernatant was 
transferred into a sterile glass bottle and 2 ml aliquots in 7% DMSO 
were stored at —80°C. 
2.2. Genomic library screening 
A total of 2x 106 clones from the amplified library were screened 
on duplicate Nytran-Plus filters (Schleicher and Schuell) with 32P-la-
beled cDNA coding for preprodermaseptin B2 [6]. Prehybridization 
was carried out for 3 h at 65°C in 0.5 M sodium phosphate buffer, pH 
7.2, containing 1 mM EDTA, 1% bovine serum albumin and 7% SDS. 
Hybridization was achieved overnight at 65°C with gentle shaking in 
20 ml of the same buffer, added with 2.5 X 106 cpm/ml of 32P-labeled 
cDNA. Filters were then washed at 65°C in 2XSSC containing 0.5% 
SDS for 10 min, then in 2XSSC with 0.1% SDS for 2X20 min, then 
in 0.2XSSC plus 0.1% SDS for 2x20 min and exposed to Kodak 
Biomax AR film overnight with an intensifying screen at —80°C. 
Positive clones were subjected to two additional rounds of plaque 
purification at low density. 
2.3. Subcloning and sequencing 
Phage DNAs, prepared from positive plaques according to Sam-
brook et al. [8] were digested with various restriction endonucleases 
(Bethesda Research Laboratories). The resulting fragments were char-
acterized by Southern blotting [9] using the same protocol as in the 
screening for prehybridization and hybridization. Based on this anal-
ysis, a 2.9-kb Sall-EcoRI fragment, a 2.3-kb Notl fragment and a 4.5-
kb EcoRl-BamHl fragment were subcloned into BlueScript pSK-vec-
tor, leading respectively to pSK3, pSK9 and pSKJ plasmids. Both 
strands of pSK3, pSK9 and pSKJ DNAs were sequenced by the 
dideoxy method [10] using the Thermo Sequenase radiolabeled termi-
nator sequencing kit (Amersham Life Science), pBlueScript universal 
primers and various gene-specific oligomer primers based on derma-
septin Bl and B2 cDNAs. The cycling termination reactions were 
carried out by cycling 15 times, each with 30 s of denaturation at 
95°C, 30 s of primer annealing at primer's Tm minus 2°C and 1 min 
of primer extension at 72°C. Computer analysis and alignments of the 
DNA sequences were performed using Clustal W [11]. 
3. Results and discussion 
Twelve DNA genomic clones in the amplified genomic li-
brary were found that strongly hybridized to the complete 
sequence of dermaseptin B2 cDNA. To determine whether 
these clones represented different dermaseptin genes, or al-
leles, they were digested with BamHl, Notl or EcoRl and 
subjected to Southern blot analysis. All of the positive clones 
gave a single and distinct band, ranging in size from 1.9 to 12 
kb, with the three enzymes, alone or in combination (not 
shown). Since there are no BamHl, Notl or EcoKl site in 
the cDNA and known intronic gene sequences (see below), 
the observed patterns indicate, according to sequencing of 
PCR phage DNA (unpublished results) that at least seven 
related dermaseptin genes, or pseudogenes, exist in an indi-
vidual frog. They further demonstrate that these genes are not 
densely clustered since a unique hybridizing band was ever 
observed in each 14-20-kb phage insert. This multigenes or-
ganization provides the frog with a large gene dosage that 
contributes to a high abundance of the dermaseptins in the 
skin. Two of these clones which exhibited very strong hybrid-
ization signals were subcloned into pBlueScript SK-vector to 
yield recombinant plasmids pSK9 and pSKJ. The latter ex-
hibited 95% nucleotide identity with pSK3, a genomic clone 
Dermaseptin B2 GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV(NII2: 
Dermaseptin Drgl GLWSNIKTAGKEAAKAALKAAGKAALGAVTDAV(NH2 ; 
Dermaseptin Drg2 GLWSKIKEAG KAVLTAAGKAALGAVSDAV (NTT2 } 
Esculentii 
LSPNLLKSLL{NH2) 
FLGALFKVASKVLPSVFCAITKKC 
GIMDTLKNLAKTAGKGALQSLVKMASCKLSGQC 
GIFSKLAGKKLKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC 
Fig. 1. A: Amino acid sequences of dermaseptins B. The sequence 
of dermaseptin B2 (also termed adenoregulin [26]) was determined 
from the mature peptide [4,26] and cDNA cloning [6]. Those of 
DRgl and DRg2 were inferred from the gene sequences reported 
here. The amino acids that are identical in the sequences are indi-
cated by an asterisk. Gaps (—) have been introduced to maximize 
sequence similarities. B: Amino acid sequences of representative 
members of the brevinin (brevinin-2E), esculentin (esculentin-1), 
temporin (temporin H) and gaegurin (gaegurin-5) families of antimi-
crobial peptides [15-20]. Cys residues that form a disulfide bridge 
are underlined. 
originating from an unamplified DNA library made from an-
other specimen of P. bicolor. 
3.1. Structure of dermaseptin gene Drg2 
The nucleotide and deduced amino acid sequences of der-
maseptin gene Drg2 present in the insert of the recombinant 
plasmid pSK9 are shown in Fig. 2. The gene is small (984 
bp1), containing a 297-bp 5'- and 317-bp 3'-untranslated re-
gions and a 368-bp protein-coding region. A comparison of 
the preprodermaseptin B2 cDNA [7] with the corresponding 
genomic sequence revealed that the coding region of the gene 
consisted of two exons, ranging from 74 (exon 1) to 157 bp 
(exon 2), interrupted by a small A+T-rich (66%) intron of 137 
bp. The intron-exon splice sites exhibited excellent adherence 
to 5'- and 3'-splice site consensus rule [12]. The first exon also 
contained the short 30-bp 5'-untranslated region and codons 
for the first 25 amino acids of the preprodermaseptin, com-
prising a 22-residue signal peptide and the first three glutamic 
residues of the acidic spacer peptide. Exon 2 contained the 
sequence coding the remaining of the acidic propiece plus a 
typical prohormone processing signal Lys-Arg and a 29-resi-
due dermaseptin sequence which is immediately followed by 
an amidation consensus sequence Gly-Glu-Gln, a stop codon 
and a 3'-untranslated region. 
The mRNA sequence as deduced from the genomic DNA is 
slightly different (90% identity) from that obtained from pre-
viously characterized dermaseptin B2 cDNA [6]. They differ in 
only 14 punctual nucleotide substitutions within their coding 
sequences, eight of which occurring at third base positions of 
codons and preserve the amino acid sequence, and in a short 
stretch of 12 nt that were absent from the gene sequence. 
Accordingly, the predicted amino acid sequence correspond-
ing to the signal peptide, the acidic propiece and the di-basic 
endoproteolytic cleavage site encoded in the gene were iden-
tical to that deduced from dermaseptin B2 mRNA. The der-
maseptin progenitor sequence encoded in the genomic struc-
ture is almost identical to that of the cDNA differing by nine 
nucleotides which cause a Ala9 for Val, Leu18 for Ala, Thr19 
for Lys and Asp31 for Glu substitutions in the dermaseptin B2 
sequence (Fig. 1). They also differ by a deletion of 12 nucleo-
tides in the gene sequence corresponding to Lysn-Glu-Ala-
Ala14 of the dermaseptin B2 sequence. Whether these differ-
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atctgggttttcattctttgctgtgataaggggctgggcacagctcagagctgt 
aggaaaaagtatcctaaatttaaaaaaaaaaattatattgcctcctaacag] G 
A 
AAAAGAGAAAATGAAGATGAGGAGGAACAAGAAGATGACGAGCAAAGTGAAATG 
K R E N E D E E E Q E D D E Q S E M 
G T T AAAGAAGCAGCA T 
AAGAGAGGACTGTGGAGTAAAATAAAAGAAGCAGGA AAAGCG 
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GAGCAAtaaagttagtaaaatgtaaagtcaatcaaattgctttgaggagcacag 
E Q *** 
ttataaataattatgtcaaatctttattaaaataaataaaaatgatatgactg 
tctgtcctttttacatacacattttatatacatttatgttttgtgtatacataa 
ttaagattatagataaaaggtaagagcactaaaatactgaagtatagggaatcc 
taaaacgagaatggagaaaacaaatgtgtggggatataagaagaataaaatttt 
agttcaaaaggaaagtatatgatagtcatgagtataattgtatacacatccaga 
GEQ 
DERMASEPTIN Drg 2 
Fig. 2. The dermaseptin Drg2 gene. A: Nucleotide sequences of coding exons are indicated by capital letters. The intronic sequence (in paren-
theses), 5'- and 3'-untranslated sequences are in lowercase letters. The transcription start site is tentatively indicated by a dagger. Nucleotides 
are numbered relative to the first nucleotide of the ATG start codon. The putative TATA box, CAAT box and polyadenylation signal are in 
bold letters. Predicted mature preprodermaseptin sequence is shown under the coding DNA. The predicted signal peptide is underlined and ma-
ture Drg2 dermaseptin sequence is double underlined. The stop codon is indicated by asterisks. Nucleotide coding sequence of dermaseptm B2 
cDNA is indicated on the top row only when it differs from that of the gene. Deletions are shown by dashes (1/nucleotide). B: Schematic rep-
resentation of the Drg2 gene. Coding exons are drawn as rectangle, the intron as a thick line. 
ences represented allelic or polymorphic variants remain to be 
elucidated. 
Two canonical polyadenylation sites were identified 71 (AT-
TAAA) and 184 (AATAAA) bp downstream of the T A A stop 
codon in the 3'-flanking region of the gene (Fig. 2). Compar-
ison with the 86-nt 3'-sequence of dermaseptin B2 c D N A 
containing a poly(A) tail demonstrated that the first site was 
used for poly(A) tailing. It is followed after =s20 bp by G T -
and TT-rich sequences present in most genes 3 ' of the poly-
adenylation site [13]. Even though further experiments will be 
requested to confirm whether the transcription initiation oc-
curs at, or near, the site indicated by the 5'-terminus of the 
dermaseptin B2 c D N A (indicated by a dagger in Fig. 2), anal-
ysis of the nucleotide sequence of the gene immediately up-
stream of the 5'-end of the c D N A start revealed a variant 
TATA-like element located at —42 from the putative tran-
scription start site, where the T A T A box is expected to be. 
One C C A A T box was found farther upstream at —79. Inter-
estingly, the A T G translation site is within a sequence (AA-
C A T G G C ) which fulfil Kozak 's criteria for strong initiation 
site except for the nucleotide in position 2 [14]. 
3.2. Exon 1 is shared by genes encoding peptides with sequences 
and activities 
Homology search of dermaseptin gene against the EMBL/ 
GenBank identified a large family of c D N A s corresponding to 
precursors of opioid and antimicrobial peptides originating 
from the skin secretions of various amphibian species. Brevi-
nins [15,16], esculentins [16,17], gaegurins [18,19] and tempo-
rins [20] are l(M-6-residue-long antimicrobial peptides (Fig. 1) 
isolated from the skin secretions of Rana brevipoda, R. escu-
lenta, R. rugosa and R. temporaria, respectively. Dermorphin, 
Ty r -D-Ala -Phe -Gly -Tyr -P ro -Se r -NH 2 skin [21], deltor-
phin A, T y r - D - M e t - P h e - H i s - L e u - M e t - A s p - N H 2 [22], also 
named dermorphin gene-associated peptide [23] or dermenke-
phalin [24], and the deltorphins B and C [25], Tyr -D-Ala-Phe-
X a a - V a l - V a l - G l y - N H 2 (where Xaa is either Asp or Glu) are 
opioid heptapeptide amides isolated from Phyllomedusa ssp. 
skin. All these peptides are synthesized as part of precursor 
proteins whose amino terminal domain includes a signal pep-
tide of 22 residues, followed by an acidic leader peptide do-
main containing 16-25 residues and a progenitor sequence of 
variable length, coding either for an antimicrobial or an 
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Drg2 tgaca-ga--ccaaacATGGCTTCCCTGAAGAAATCTCTTTTCCTTGTACTATTCCTTGGATTGGTCTCTCTTTCTATTTGTGAAGAAGAG 
Derm ttacaaga-CCC-aacATGTCTTTCTTGAAGAAATCGCTTCTCCTTATACTTTTCCTTGGATTGGTTTCCCTTTCCGTTTGTAAAGAAGAA 
Delt taacaaga-CCC-aacATSTCTTTCTTGAAGAAATCTCTTTTCCTTGTACTGTTCCTTGGATTAGTGTCCCATTCCGTTTGTAAAGAAGAG 
Brev-2E CtacccgagcccaaacATGTTCACCATGAAGAAATCCCTGTTACTCATTTTCTTTCTTGGGACCATCTCCTTATCTCTCTGTCAGGAAGAG 
Tempo H ctacccgagcccaaagATGTTCACCTTGAAGAAATCCCTGTTACTCCTCTTTTTCCTTGGGACCATCAACTTATCTCTCTGTGAGGAAGAG 
Gaeg-5 ctacccgagcccaaagATGTTCACCTTGAAGAAATCCCTGTTATTTCTTTTCTTCCTTGGGACCATCAGCTTATCTCTCTGAGGAAGAGAG 
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Fig. 3. Nucleotide (top) and amino acid (bottom) sequence alignments of predicted signal peptides (underlined) and amino end of the acidic 
pro pieces encoded by exon 1 of gene Drg2 and by preprodermorphin (DRM) [27], preprodeltorphins (DELT) [28], preprobrevinin-2E (Brev-
2E) [17], preprotemporin H (Tempo H) [20] and preprogaegurin-5 (Gaeg-5) [19] mRNAs. Asterisks denote identical nucleotides or amino acids 
between sequences. Part of the 5'-untranslated regions of the respective gene or cDNA sequences are also shown in lower case letters. Gaps 
(—) have been introduced to maximize similarity. The ATG start codon is underlined. Nucleotides and amino acids corresponding to the begin-
ning of the acidic propiece are in bold letters. 
opioid peptide. As depicted in Fig. 3, the coding nucleotide 
sequence in dermaseptin genes exon 1 comprising the 22-res-
idue signal peptide and the first three residues of the acidic 
propiece shares 48% identity (50% at the amino acid level) 
with the corresponding regions of the esculentins, brevinins, 
temporins, gaegurins, dermorphin and deltorphins cDNAs. 
Also, 5'-region in the gene is ~ 6 0 % identical to 5'-untrans-
lated regions of cDNAs at least over the first 13 bp immedi-
ately upstream of the ATG initiation codon, but sequences 
diverge beyond that point. This suggests that the dermaseptin, 
gaegurin, brevinin, esculentin, temporin, dermorphin and del-
torphin gene subfamilies have evolved with a conserved 'se-
cretory cassette' exon followed by exon(s) encoding end prod-
ucts with stickingly different sequences and biological 
activities. The duplication and recombitional events that pro-
moted the association of such a homologous secretory exon 
with nucleotide sequences coding for a variety of end products 
in various amphibian species remain to be elucidated but are 
likely to have occurred at the very early stages of evolution. 
3.3. Structure of dermaseptin gene Drglg2 
Dermaseptin gene Drglg2 presents in the insert of the re-
combinant plasmid pSK3 was sequenced, including over 1830 
and 487 bp of upstream and downstream untranslated sequen-
ces, respectively. As shown in Fig. 4, Drglg2 and Drgl are 
nearly identical at both ends. Within the first 300 nt of their 
5'-flanking regions there were 46-bp differences, 33 of these 
are located more than 100 nt upstream of the presumed 
mRNA start. The TATA-like elements and CCAAT boxes 
occurred in identical positions in the two genes. The overall 
similarity between the genes is also present for the 317 nt 
forming the 3'-untranslated part of Drgl, (75% identity) in-
cluding a poly(A) signal at identical positions (Fig. 4). The 
coding structure of the Drglgl gene comprised two exons 
homologous to those of Drgl (98% and 90% nucleotide iden-
tity, respectively), interrupted by a short intron, then a puta-
tive second intron of 65 nt and finally a third potential exon 
encoding part of an acidic propiece followed by a second 
dermaseptin progenitor sequence. The first two exons encoded 
identical signal peptides and acidic propieces in both genes, 
and predicted dermaseptin progenitor sequences differ in four 
amino acids and insertion of four residues in the central core 
of the mature peptide issued from Drglgl (Fig. 1). Surpris-
ingly, the intron that interrupts the first two exons exhibits a 
strong sequence conservation along its entire length in both 
genes (83% nucleotide sequence identities). This suggests that 
the two genes expanded recently without sufficient time to 
allow the intron sequence to drift. 
The nucleotide sequence of the putative intron downstream 
from exon 2 in Drglgl was found to be largely similar 
( = 66% identity) to the first 66 nt of the 3'-untranslated re-
gions of both genes. Whereas this intronic sequence also 
closely corresponds to the 3'-untranslated part of mature pre-
prodermaseptin B2 mRNA (70% identity), no equivalent of 
the poly(A) sites located 71 {Drgl) or 55 bp (Drglgl) down-
stream of the TAA stop codon in the 3'-flanking regions of 
the genes can be found at the end of the putative intronic 
sequence. The third potential coding exon in gene Drglgl 
comprises 120 bp and contains the genetic information for a 
small part of the acidic propiece plus one copy of a derma-
septin progenitor sequence which is identical to that encoded 
in gene Drg2. Altogether, these findings suggest that the struc-
ture of Drglg2 has arisen from internal duplication and fusion 
of an individual segment of a Drgl-like ancestral gene, encom-
passing coding nucleotides of its second exon and ~ 60 bp of 
the 3'-flanking region. The differences between the sequences 
Fig. 4. The dermaseptin Drglg2 gene. A: Nucleotide sequences of coding exons are indicated by capital letters. The intronic sequence, 5'- and 
3'-untranslated sequences are shown in lowercase letters. The putative transcription start site is indicated by a dagger. Nucleotides are num-
bered relative to the first nucleotide of the ATG start codon. The putative TATA box, CAAT box and polyadenylation signal are in bold let-
ters. Predicted mature preprodermaseptin sequence is shown under the coding DNA. The predicted signal peptide is underlined and mature 
Drgl and Drg2 dermaseptin sequences are double underlined. The stop codons are indicated by asterisks. B: Schematic representation of the 
Drglg2 gene. Coding exons are drawn as rectangle, introns as thick lines. 
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cgatcctcagatgacactatttaatcccttcctgacagcc 
agttataataatatggctcttcattttttttattcccctccttccaagagcaat 
agcttaatatttatccatctacataaaccttttagggcttttacttcacggtac 
aagatgtactttctattggtgtcattgactgtaacatagaatgaactgaaaaat 
gcagaaaaaaattatgggcaacatgtatgtattttggcgctcagacaccatttt 
tttgttttggattagtagcctagaatgtgcctgaattctataaacctgttctag 
tgcgggtcttagatttagcgctttctaactacaaagcgaaaattctagctcagg 
taaaccccttttaacgtgctcttcctgctccagcagtaccgcgcctggttttgc 
cattcaaaagtcattgatgtgtagaatgatgcaattttagtgtgacactcctca 
agcatgcccccattctcagcattacaatgagcctaatattggagtgctcctgat 
taaaaataaagcgaacagggctgcgcagttttcgggctgaaaagactttagaag 
ccagccccatacataaatgttgccctatgtgttttatgtattctgtaggtagat 
acaatttaggcaatagcaaatatgtagtgttttctttagtaccatgaaaaaatc 
caaatatcctctatttcttaaatctgcactgcagcgccattttctgcaaccaat 
aacttttttgtaccttcacctctgagtgaggatgcattttctcaggctgatgtt 
aatttgtttggtaccattttgtgatatatatgacatttggatcactttttattc 
caatttttagaggacttgaaacgaccaaaaaaaataaaatttttgcgtttgtaa 
tttttttcttctacagtgttcagtctacaggataaatcaggttacattgtaata 
gatcagacttctacagacttggtaatacaaattatgtgtaaccttttatctttg 
tgtatgtaaaatggcaaaaattggttgattagcttatttcaaagttccctcatc 
tcattttcagatatagtaatttcttgtgtgtaaagtatggtataattgatcatt 
ctttgcttagagaagtggttctcagcctctaatgcaattatgccactggcctgt 
ctaaattaattactctaaagcagctgctacaatactacttcaacctctaggcta 
gaacatagatctatgtcactattatcattttataaagagggcaacttttcttca 
ttatattacttactcctagacaggtagagggattggagggagtggagtcaaaga 
tacctgaagcatgtctctctcttagagcctcgtccaaaatttacattacagata 
tgtttaaatgtcttctgcctgtctggcagcaagtaataggctgatatagatatg 
tgttagattccacaaaactattaaaaaaagaagcaaatgtctgttactctgctt 
tcacacgtaaatttctgacaaaaaagtaccaaaaatgctccaacattaattact 
gtgcctttctgcacaaaaacatccaaagacacataaaaaagagccaaaaaagct 
cagtttttattgctttttggatgcatttttgtgtatttttaaatatttattaac 
attgcaacaattaagtagagctaaattgttatcattgtcaacctatccaatct 
taactttttttttccttatattttatactaataaaacattttattttcaatta 
agaagagaaatccaaacctgtttaactaatataaatctttttgacagaccaaaa 
t 
ATGGCTTCCCTGAAGAAATCTCTTTTCCTTGTACTATTCCTTGGATTGGTCTCT 
M A S L K K S L F L V L F L G T , V S 
CTTTCTATATGTGAAGAAGA [gtaagtactaatatattataatgaaacaatga 
L S I C E E E 
atctgggttttcattctttgctgtgataagggctgggcccagctcagagctgta 
ggaaagtatcataagtttttaaaaaaaattatattgcctcctaacacag] G 
AAAAGAGAAAATGAAGATGAGGAGGAACAAGAAGATGACGAGCAAAGTGAAATG 
K R E N E D E E E Q E D D E Q S E M 
AAGAGAGGGCTGTGGAGTAACATAAAAACAGCAGGAAAAGAAGCAGCAAAAGCT 
K R G L W S N I K T A G K E A A K A 
GCATTAAAAGCTGCAGGAAAAGCAGCTTTAGGTGCAGTTACTGATGCGGTGGGA 
A L K A A G K A A L G A V T D A V G 
GAGCAAtaaattaataaaatataaaatcaatcaaattactctaaaaaacacaat 
E Q •** 
tatacataattatgccaaatgacgagcaaag TGAAATGAAGAGAGGGCTGTGG 
E M K R G L W 
AGTAAAATTAAAGAAGCAGGAAAAGCTGTATTAACAGCTGCAGGAAAAGCAGCT 
S K I K E A G K A V L T A A G K A A 
TTAGGTGCAGTTTCTGATGCGGTGGGAGAGCAAtaaagttagtaaaattgccct 
L G A V S D A V G E Q *** 
gagaaacacaattatcaataattatgtcaaatctatattaaaataaattaaaa 
tgatatgactgtctgtcctttttacatatacattttatattgtatacataatta 
agattatagataaaaggtaagagcactaaaatgctgaagtatagggaatcataa 
gacaagagtggagaaaacaaatgtgtggggacataagaagaataaaactttagt 
ttaaaaaggaaaattatatgatagtcatgagtttaaattgtatataacatccag 
aaagtaggtttctaccattggaggagggagttttttttttttttagatgataat 
aacttgggggttcatgggttcacacataccatagtctaaagaaagactaggctt 
atatataaagttacaaaagtcattgtgtgtggcttctagtccttttaaaattat 
aatatggtaactaaatcattgcaagattcaacacttaaca 
GEQ 
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of the first intron in both genes consist of only a few nucleo-
tides. Also, strong conservation of the sequences exist between 
the second putative intron in Drglg2 and 3'-flanking regions 
of both genes, as well as with the 3'-untranslated part of 
dermaseptin B2 mRNA. It thus appears likely that expansion 
of Drg2 and Drglg2 dermaseptin genes through duplication as 
well as internal amplification were very recent events in the 
evolutionary process. 
Although we have not confirmed the transcription and sub-
sequent translation of Drglg2 gene, regions encompassing 
coding exons 1 and 2 may well be expressed through incom-
plete or alternate splicing of the transcribed pre-mRNA (Fig. 
4). For instance, skipping exon 3 by using donor site at posi-
tion 393 in intron 2 and 3'-acceptor site in position 590 within 
the 3'-flanking region would yield a prepro form containing a 
signal peptide, a complete acidic propiece and a single copy of 
a dermaseptin Drgl progenitor sequence. The sequence en-
coding the second dermaseptin copy is located in exon 3, 
which begins with the final two residues for the acidic pro-
piece plus the Lys-Arg doublet. Although numerous possible 
scenarios could offer a possibility to express this dermaseptin 
copy (for instance, skipping of exon 2 by using 5'-donor site 
at position 75 in intron 1 and 3'-acceptor site in position 457 
in intron 2), the resulting prepro form should only contain five 
among 21 residues of the acidic pro segment, i.e. EEDEM. 
Such a shorter version of a dermaseptin precursor has not 
been yet isolated. Meanwhile, even though these models are 
plausible and the sequence of gene Drglg2 has been obtained 
from two genomic banks both in agreement, the possibility 
that this gene is a pseudogene, or that exon 3 represents a 
dermaseptin exon which has been silenced during evolution 
cannot be ruled out. 
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